Mitsuru Watanabe

发表

Long-term use of interferon-β in multiple sclerosis increases Vδ1−Vδ2−Vγ9− γδ T cells that are associated with a better outcome

J. Kira, Y. Yoshikai, N. Isobe, 2019, Journal of Neuroinflammation.

Case of central nervous system inflammatory disease in late pregnancy

J. Kira, N. Isobe, T. Matsushita, 2019, Clinical and Experimental Neuroimmunology.

A new clustering method identifies multiple sclerosis‐specific T‐cell receptors

J. Kira, J. Glanville, N. Isobe, 2021, Annals of clinical and translational neurology.

Th1 cells downregulate connexin 43 gap junctions in astrocytes via microglial activation

J. Kira, A. Suzumura, H. Takeuchi, 2016, Scientific Reports.

Anti‐KIR4.1 antibodies in Japanese patients with idiopathic central nervous system demyelinating diseases

J. Kira, R. Yamasaki, Shihoko Imamura, 2013 .

[Remission of lymphomatosis cerebri induced by corticosteroid and high-doses intravenous methotrexate].

H. Toda, N. Nishida, S. Matsumoto, 2012, Rinsho shinkeigaku = Clinical neurology.

Early and extensive alterations of glial connexins, distal oligodendrogliopathy type demyelination, and nodal/paranodal pathology are characteristic of multiple system atrophy

T. Iwaki, J. Kira, R. Yamasaki, 2022, Brain pathology.

Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study

S. Shimohama, J. Kira, S. Kikuchi, 2016, Journal of Neuroinflammation.

Copy number variations in multiple sclerosis and neuromyelitis optica

J. Kira, R. Yamasaki, N. Isobe, 2015, Annals of neurology.

Autoantibodies to neural antigens in CNS demyelinating disorders.

T. Kondo, M. Watanabe, Mitsuru Watanabe, 2016 .

Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis

F. Piehl, J. Kira, J. Lambert, 2023, Journal of Neurology, Neurosurgery, and Psychiatry.

Serum GFAP and neurofilament light as biomarkers of disease activity and disability in NMOSD

J. Kira, J. Kuhle, C. Barro, 2019, Neurology.

Long-lasting pain and somatosensory disturbances in children with myelin oligodendrocyte glycoprotein antibody-associated disease

J. Kira, Y. Sakai, S. Ohga, 2023, European Journal of Pediatrics.

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

S. Tsuji, T. Kanda, M. Hirata, 2021, Scientific reports.

Genetic factors for susceptibility to and manifestations of neuromyelitis optica

J. Kira, N. Isobe, T. Suenaga, 2020, Annals of clinical and translational neurology.

Iguratimod Ameliorates the Severity of Secondary Progressive Multiple Sclerosis in Model Mice by Directly Inhibiting IL-6 Production and Th17 Cell Migration via Mitigation of Glial Inflammation

R. Yamasaki, N. Isobe, H. Yamaguchi, 2023, Biology.

Long-term use of interferon-β in multiple sclerosis increases Vδ1−Vδ2−Vγ9− γδ T cells that are associated with a better outcome

J. Kira, Y. Yoshikai, N. Isobe, 2019, Journal of Neuroinflammation.

Antibodies to neural and non-neural autoantigens in Japanese patients with CNS demyelinating disorders

T. Kondo, Toshiyuki Takahashi, K. Nomura, 2014, Journal of Neuroimmunology.

Myotonia associated with caveolin‐3 mutation

J. Kira, S. Nagafuchi, Y. Ohyagi, 2012, Muscle & nerve.

Oral phase dysphagia in facial onset sensory and motor neuronopathy

J. Kira, R. Yasumatsu, R. Yamasaki, 2018, Brain and behavior.

Oligodendroglial connexin 47 regulates neuroinflammation upon autoimmune demyelination in a novel mouse model of multiple sclerosis

J. Kira, S. Nagata, R. Yamasaki, 2020, Proceedings of the National Academy of Sciences.

Early and extensive spinal white matter involvement in neuromyelitis optica

Satoshi O. Suzuki, A. Hiwatashi, T. Iwaki, 2017, Brain Pathology.

Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder

C. Granziera, N. Hadjikhani, L. Kappos, 2022, Neurology - Neuroimmunology Neuroinflammation.

Astroglial connexin 43 is a novel therapeutic target for chronic multiple sclerosis model

N. Isobe, H. Yamaguchi, K. Masaki, 2024, Scientific reports.

HLA genotype-clinical phenotype correlations in multiple sclerosis and neuromyelitis optica spectrum disorders based on Japan MS/NMOSD Biobank data

T. Kanda, S. Shimohama, J. Kira, 2021, Scientific Reports.

Two susceptible HLA-DRB1 alleles for multiple sclerosis differentially regulate anti-JC virus antibody serostatus along with fingolimod

J. Kira, R. Yamasaki, N. Isobe, 2020, Journal of Neuroinflammation.

Risk HLA-DRB1 alleles differentially influence brain and lesion volumes in Japanese patients with multiple sclerosis

A. Hiwatashi, J. Kira, R. Yamasaki, 2020, Journal of the Neurological Sciences.

Environmental risk factors for multiple sclerosis in Japanese people.

J. Kira, R. Yamasaki, N. Isobe, 2019, Multiple sclerosis and related disorders.

Spinal cord involvement by atrophy and associations with disability are different between multiple sclerosis and neuromyelitis optica spectrum disorder

A. Hiwatashi, J. Kira, R. Yamasaki, 2019, European journal of neurology.

Distinct microglial and macrophage distribution patterns in the concentric and lamellar lesions in Baló's disease and neuromyelitis optica spectrum disorders

Satoshi O. Suzuki, T. Tabira, T. Iwaki, 2020, Brain pathology.